FDA Brief

Company record

Reliance Life Sciences Private Limited

1 FDA warning letter since 2023 and 4 recalls in the last 12 months.

Get an email the day FDA posts anything new about Reliance Life Sciences Private Limited.

Warning letters

  1. Reliance Life Sciences Private Limited

    FDA warned India's Reliance Life Sciences over falsified microbiology records and aseptic failures in sterile drug production, prompting a recall.

    High risk

Recalls

ReportedClassFirmProduct and reason
Jul 15 Class II Reliance Life Sciences Private Limited
Drug
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Lack of Sterility Assurance
Jul 15 Class II Reliance Life Sciences Private Limited
Drug
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Lack of Sterility Assurance
Jul 15 Class II Reliance Life Sciences Private Limited
Drug
Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0834-01
Lack of Sterility Assurance
Jul 15 Class II Reliance Life Sciences Private Limited
Drug
Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01
Lack of Sterility Assurance